Zinc L-carnosine complex polaprezinc for pica and polydipsia

Trial Profile

Zinc L-carnosine complex polaprezinc for pica and polydipsia

Recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Nov 2016

At a glance

  • Drugs Polaprezinc (Primary)
  • Indications Pica
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Nov 2016 Planned number of patients changed from 10 to 20.
    • 11 Mar 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan.
    • 11 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top